|
Re: Confirmation bias.....
|
2
|
Resverlogix Corp.
|
May 02, 2017 02:33AM
|
|
New analyst coverage with a $12.50 valuation
|
3
|
Resverlogix Corp.
|
May 02, 2017 02:51AM
|
|
Re: New analyst coverage with a $12.50 valuation
|
4
|
Resverlogix Corp.
|
May 02, 2017 03:12AM
|
|
Re: Confirmation bias.....
|
2
|
Resverlogix Corp.
|
May 02, 2017 12:34PM
|
|
Re: Another great read from Fundamentals6
|
3
|
Zenith Epigenetics
|
May 03, 2017 02:45AM
|
|
Re: Got a reply....
|
1
|
Resverlogix Corp.
|
May 03, 2017 03:38AM
|
|
Re: Sarah's latest response....
|
4
|
Resverlogix Corp.
|
May 03, 2017 05:48PM
|
|
Re: Bear Dsmc
|
4
|
Resverlogix Corp.
|
May 03, 2017 06:14PM
|
|
Re: Sarah's last sentence....
|
4
|
Resverlogix Corp.
|
May 04, 2017 12:54AM
|
|
Re: Where are we "METER"...
|
3
|
Resverlogix Corp.
|
May 05, 2017 11:13AM
|
|
Re: Where are we "METER"...
|
4
|
Resverlogix Corp.
|
May 05, 2017 12:07PM
|
|
Re: Analyst Coverage, etc.
|
5
|
Resverlogix Corp.
|
May 07, 2017 07:57PM
|
|
Re: New patent application - USA Inventor
|
5
|
Resverlogix Corp.
|
May 08, 2017 04:45PM
|
|
Re: A couple Q2 events for Zenith
|
2
|
Zenith Epigenetics
|
May 10, 2017 10:40AM
|
|
Re: A couple Q2 events for Zenith
|
3
|
Zenith Epigenetics
|
May 10, 2017 12:32PM
|
|
Re: A couple Q2 events for Zenith
|
1
|
Zenith Epigenetics
|
May 10, 2017 12:54PM
|
|
Re: A lesson on futility analyses from the CETP inhibitors
|
5
|
Resverlogix Corp.
|
May 11, 2017 04:00PM
|
|
Re: A lesson on futility analyses from the CETP inhibitors
|
5
|
Resverlogix Corp.
|
May 11, 2017 11:50PM
|
|
Re: A lesson on futility analyses from the CETP inhibitors
|
6
|
Resverlogix Corp.
|
May 12, 2017 10:57AM
|
|
Re: A lesson on futility analyses from the CETP inhibitors
|
3
|
Resverlogix Corp.
|
May 12, 2017 01:43PM
|
